The curves indicated that the high CCNB2 expression was associated with shorter survival times compared with the low CCNB2 expression in HCC patients with tumor stage 2 (log-rank P = 0.022, Figure 5(h)) and tumor stage 3 (log-rank P = 0.011, Figure 5(i)). This evidence concerns the gene CCNB2 and neoplasm.